Atlas Trials

A Relative Bioavailability Study of Two Formulations of BCX7353

Clinical trial NCT03202784 · COMPLETED

Trial details

NCT number
NCT03202784
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hereditary Angioedema
Start date
2017-02-27
Primary completion
2017-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.